The University of Chicago Header Logo

Connection

James L. LaBelle to Antigens, CD34

Back to Details
This is a "connection" page, showing publications James L. LaBelle has written about Antigens, CD34.
James L. LaBelle
Connection Strength
0.218
Antigens, CD34
  1. CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease. N Engl J Med. 2023 Aug 31; 389(9):820-832.
    View in: PubMed
    Score: 0.218
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.